Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy
Patricio V. Sepulveda(Baker Heart and Diabetes Institute), Paul Gregorevic(Baker Heart and Diabetes Institute)
Cited by 39
Related Papers
The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size
|Nature Communications|2015|156
Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia
|Cancer Research|2016|84
Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease
|Nature Communications|2021|48
Using AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size
|Scientific Reports|2016|22
Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes
|The FASEB Journal|2020|16